Richard B. Lanman
Dr. Rick Lanman | |
|---|---|
Dr. Lanman at his home in 2023 | |
| Born | Richard Burnham Lanman Jr. 1955 (age 69–70) |
| Nationality | American |
| Education | Stanford University, B.S. 1977 Northwestern University School of Medicine, M.D. 1980 |
| Occupation(s) | Physician-scientist and Naturalist |
| Years active | 1978-present |
| Known for | Biomarkers in Cardiovascular disease and Cancer, and Historical ecology |
| Relatives | Martha Lee Hopkins Struever (mother) Fritz Lanman (son) James Lanman (son) |
| Medical career | |
| Profession | Medical Doctor |
| Institutions | Guardant Health, Inc. Veracyte, Inc. diaDexus, Inc. Atherotech, Inc. San Jose Medical Group, Inc. Kaiser Permanente |
| Research | Cancer genomics, Precision oncology, Cardiovascular Biomarkers, Thyroid cancer, Interstitial lung disease, Psychiatry, Ecology |
Richard Burnham Lanman is an American biotechnology entrepreneur, physician scientist, and naturalist. His contributions relate to improving diagnosis and utilization of less invasive medical procedures, most recently as Global Chief Medical Officer at Guardant Health, Inc., a precision oncology company that developed a blood test replacing invasive tissue biopsies to sequence tumor DNA and improve cancer treatment selection. Lanman has worked in five different medical specialties, oncology, cardiology, endocrinology, pulmonology, and psychiatry, as well as historical ecology, and has authored or co-authored 130 peer-reviewed scientific publications.